Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient?

被引：4
|
作者：
Mesguich, Charles [1 ]
Bouabdallah, Krimo [1 ]
Bordenave, Laurence [1 ]
Milpied, Noel [1 ]
Hindie, Elif [1 ]
机构：
[1] CHU Bordeaux, Ave Magellan, F-33604 Pessac, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷 / 11期
关键词：
INTERNATIONAL PROGNOSTIC SCORE; POSITRON-EMISSION-TOMOGRAPHY; TRIAL; SCAN;
D O I：
10.2967/jnumed.120.242594
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1694 / 1695
页数：2
相关论文
共 50 条
  • [31] Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
    Villa, Diego
    Sehn, Laurie H.
    Aquino-Parsons, Christina
    Tonseth, Petter
    Scott, David W.
    Gerrie, Alina S.
    Wilson, Donald
    Benard, Francois
    Gascoyne, Randy D.
    Slack, Graham W.
    Farinha, Pedro
    Morris, James
    Pickles, Tom
    Connors, Joseph M.
    Savage, Kerry J.
    HAEMATOLOGICA, 2018, 103 (12) : E590 - E593
  • [32] Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients
    Zinzani, Pier Luigi
    Rigacci, Luigi
    Stefoni, Vittorio
    Broccoli, Alessandro
    Puccini, Benedetta
    Castagnoli, Antonio
    Vaggelli, Luca
    Zanoni, Lucia
    Argnani, Lisa
    Baccarani, Michele
    Fanti, Stefano
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (01) : 4 - 12
  • [33] Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)
    Kusumoto, Shigeru
    Munakata, Wataru
    Machida, Ryunosuke
    Terauchi, Takashi
    Onaya, Hiroaki
    Oguchi, Masahiko
    Iida, Shinsuke
    Nosaka, Kisato
    Suzuki, Yasuhiro
    Harada, Yasuhiko
    Miyazaki, Kana
    Maruta, Masaki
    Fukuhara, Noriko
    Toubai, Tomomi
    Kubota, Nobuko
    Ohmachi, Ken
    Saito, Toko
    Rai, Shinya
    Mizuno, Ishikazu
    Fukuhara, Suguru
    Takeuchi, Mai
    Tateishi, Ukihide
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    CANCER SCIENCE, 2024, 115 (10) : 3384 - 3393
  • [34] End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
    Chohan, Karan L.
    Young, Jason R.
    Lester, Scott
    Moustafa, Muhamad Alhaj
    Rosenthal, Allison
    Tun, Han W.
    Hoppe, Bradford S.
    Johnston, Patrick B.
    Micallef, Ivana N.
    Habermann, Thomas M.
    Ansell, Stephen M.
    HAEMATOLOGICA, 2023, 108 (06) : 1697 - 1701
  • [35] Pediatric Hodgkin Lymphoma Predictive value of interim 18F-FDG PET/CT in therapy response assessment
    Ferrari, Cristina
    Asabella, Artor Niccoli
    Merenda, Nunzio
    Altini, Corinna
    Fanelli, Margherita
    Muggeo, Paola
    De Leonardis, Francesco
    Perillo, Teresa
    Santoro, Nicola
    Rubini, Giuseppe
    MEDICINE, 2017, 96 (05)
  • [36] Interim FDG-PET/CT for Response Assessment of Lymphoma
    Zeman, Merissa N.
    Akin, Esma A.
    Merryman, Reid W.
    Jacene, Heather A.
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 371 - 388
  • [37] Interim PET in lymphoma: a step towards standardization
    Meignan, Michel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) : 1821 - 1823
  • [38] Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?
    Gallamini, Andrea
    Kostakoglu, Lale
    BLOOD, 2012, 120 (25) : 4913 - 4920
  • [39] Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience
    Hamid, Muhammad Saad
    Rutherford, Sarah C.
    Jang, Hyejeong
    Kim, Seongho
    Patel, Krish
    Bartlett, Nancy L.
    Malecek, Mary-Kate
    Watkins, Marcus P.
    Maddocks, Kami J.
    Bond, David A.
    Feldman, Tatyana A.
    Magarelli, Gabriela
    Advani, Ranjana H.
    Spinner, Michael A.
    Evens, Andrew M.
    Shah, Mansi
    Ahmed, Sairah
    Stephens, Deborah M.
    Allen, Pamela
    Tees, Michael T.
    Karmali, Reem
    Cheson, Bruce D.
    Sarraf, Maryam
    Strouse, Christopher
    Bailey, Neil A.
    Pagel, John M.
    Ramchandren, Radhakrishnan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07) : E435 - E442
  • [40] The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
    Bari, Alessia
    Marcheselli, Raffaella
    Sacchi, Stefano
    Re, Alessandro
    Pagani, Chiara
    Tucci, Alessandra
    Botto, Barbara
    Vitolo, Umberto
    Molinari, Anna Lia
    Puccini, Benedetta
    Pulsoni, Alessandro
    Santoro, Armando
    Tani, Monica
    Nassi, Luca
    Meli, Erika
    Pavone, Vincenzo
    Bonfichi, Maurizio
    Evangelista, Andrea
    Gioia, Daniela
    Levis, Alessandro
    Zinzani, Pierluigi
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 277 - 282
12345